Baltimore, MD, United States of America

Matthew C Mulvey



 

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 63(Granted Patents)


Location History:

  • New York, NY (US) (2010 - 2014)
  • Baltimore, MD (US) (2011 - 2019)
  • North Bethesda, MD (US) (2019)
  • Gaithersburg, MD (US) (2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Matthew C Mulvey

Introduction

Matthew C Mulvey is a prominent inventor based in Baltimore, MD (US), known for his significant contributions to the field of cancer treatment. With a total of 10 patents to his name, Mulvey has focused on developing innovative therapies that utilize oncolytic herpes simplex virus (HSV) to selectively target and destroy cancer cells.

Latest Patents

One of Mulvey's latest patents involves variants of herpes simplex virus that selectively infect and replicate in cancer cells, particularly bladder cancer cells. The invention details HSV strains that maintain intact endogenous Us11 and Us12 genes while replacing genes encoding ICP34.5 with a gene encoding Us11 fused to an HSV immediate early promoter. Additionally, these variant HSVs include one or more heterologous genes encoding immunomodulatory polypeptides. The methods and compositions derived from this invention aim to provide effective treatments for cancer in affected subjects.

Career Highlights

Throughout his career, Mulvey has worked with esteemed institutions such as New York University and Benevir Biopharm, Inc. His work has been instrumental in advancing the understanding and application of oncolytic viruses in cancer therapy.

Collaborations

Mulvey has collaborated with notable professionals in the field, including Ian J Mohr and Leo Einck. These partnerships have contributed to the development of innovative therapeutic strategies.

Conclusion

Matthew C Mulvey's work in the realm of oncolytic herpes simplex virus represents a significant advancement in cancer treatment. His innovative approaches and collaborations continue to pave the way for new therapeutic options in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…